CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病预防

科研文章

荐读文献

Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel Fractional flow reserve derived from CCTA may have a prognostic role in myocardial bridging Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies The Objective Physical Activity and Cardiovascular Disease Health in Older Women (OPACH) Study Circadian-Regulated Cell Death in Cardiovascular Diseases Sequence variations in PCSK9, low LDL, and protection against coronary heart disease Sleep quality and risk of coronary heart disease-a prospective cohort study from the English longitudinal study of ageing Primary Prevention of Sudden Cardiac Death Initial Invasive or Conservative Strategy for Stable Coronary Disease Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association

Review ArticleVolume 75, Issue 20, May 2020

JOURNAL:JACC Article Link

Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review

L Cho, M Davis, and for the ACC CVD Womens Committee Members. Keywords: adverse pregnancy outcomes; aspirin; atrial fibrillation; cardiovascular disease; gestational diabetes

ABSTRACT

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for women in the United States and worldwide. There has been no American College of Cardiology (ACC)/American Heart Association guideline update specifically for the prevention of CVD in women since 2011. Since then, the body of sex-specific data has grown, in addition to updated hypertension, cholesterol, diabetes, atrial fibrillation, and primary prevention guidelines. The ACC CVD in Women Committee undertook a review of the recent guidelines and major studies to summarize recommendations pertinent to women. In this update, the authors address special topics, particularly the risk factors and treatments that have led to some controversies and confusion. Specifically, sex-related risk factors, hypertension, diabetes, hyperlipidemia, anticoagulation for atrial fibrillation, use of aspirin, perimenopausal hormone therapy, and psychosocial issues are highlighted.